精神分裂症家族史负荷增加与病前智商降低与治疗抵抗相关
该研究基于瑞典全国登记样本(n=24706)及部分基因组数据亚组(n=4936),分析治疗抵抗性精神分裂症(TRS)的临床与基因组相关因素。结果发现精神分裂症家族史负荷最高四分位与TRS显著相关(aOR=1.31,P=4.8×10^-8),男性病前智商每降低1个标准差与TRS风险增加相关(最小aOR=0.94,P=0.002),但常见变异风险评分、拷贝数变异及罕见外显子负荷与TRS无显著关联。
要点
- 精神分裂症家族史负荷最高四分位者TRS风险显著升高(aOR=1.31)。
- 男性病前智商降低1个标准差与TRS风险增加相关(最小aOR=0.94)。
- 常见变异风险评分、拷贝数变异及罕见变异负荷未显示与TRS显著相关。
核心结论
- 基因组直接测量指标未与TRS显著关联,但男性病前智商和精神分裂症家族史与TRS显著相关。
研究设计与样本
- 基于瑞典全国人口样本(n=24706)的流行病学与遗传流行病学建模分析,并在具有常见变异遗传风险评分、罕见拷贝数变异负荷和罕见外显子负荷的亚组(n=4936)中进一步分析。
主要发现
- 精神分裂症家族史负荷最高四分位与最低四分位相比,TRS的调整比值比(aOR)为1.31(P=4.8×10^-8)。
- 男性病前智商降低1个标准差与TRS风险增加显著相关(最小aOR=0.94,P=0.002)。
- 四种精神疾病遗传风险评分及两种认知特质遗传风险评分与TRS均无显著关联(精神分裂症遗传风险评分:aOR=1.07,P=0.067)。
- 拷贝数变异和罕见变异负荷测量与TRS的关联未达到预设统计显著性阈值(所有P≥0.005)。
临床怎么用
- 评估精神分裂症患者治疗抵抗风险时,可关注家族史负荷和男性病前智商水平。
局限性
- 基因组分析仅限具有广泛基因组数据的亚组(n=4936),可能限制遗传关联的检出效力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A high proportion of those with schizophrenia experience treatment non-response, placing them at higher risk for mortality and suicide attempts, compared to treatment responders. The clinical, social, and economic burden of treatment-resistant schizophrenia (TRS) are substantial. Previous genomic and epidemiological studies of TRS were often limited by sample size or lack of comprehensive genomic data. We aimed to systematically understand the clinical, demographic, and genomic correlates of TRS using epidemiological and genetic epidemiological modelling in a Swedish national population sample (n = 24,706) and then in a subgroup with common variant genetic risk scores, rare copy-number variant burden, and rare exonic burden (n = 4936). Population-based analyses identified increasing schizophrenia family history to be significantly associated with TRS (highest quartile of familial burden vs. lowest: adjusted odds ratio (aOR): 1.31, P = 4.8 × 10-8). In males, a decrease of premorbid IQ of one standard deviation was significantly associated with greater risk of TRS (minimal aOR: 0.94, P = 0.002). In a subset of cases with extensive genomic data, we found no significant association between the genetic risk scores of four psychiatric disorders and two cognitive traits with TRS (schizophrenia genetic risk score: aOR = 1.07, P = 0.067). The association between copy number variant and rare variant burden measures and TRS did not reach the pre-defined statistical significance threshold (all P ≥ 0.005). In conclusion, direct measures of genomic risk were not associated with TRS; however, premorbid IQ in males and schizophrenia family history were significantly correlated with TRS and points to new insights into the architecture of TRS.
引用
- Kowalec K, Lu Y, Sariaslan A, et al. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study. Mol Psychiatry. 2019. PMID: 31712719. doi:10.1038/s41380-019-0575-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。